EMERGENT BIOSOLUTIONS INC. Tax Withholding Paid on Stock Awards
EMERGENT BIOSOLUTIONS INC. (EBS) reported Tax Withholding Paid on Stock Awards of $3.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $400.00K, a 100.00% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $2.80M, a 460.00% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $400.00K, a 33.33% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $300.00K, a 0.00% change year-over-year.
- EMERGENT BIOSOLUTIONS INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.40M, a 16.67% increase from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $1.20M, a 52.00% decline from fiscal 2023.
- EMERGENT BIOSOLUTIONS INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $2.50M, a 57.63% decline from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $5.90M, a 57.25% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 3 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month as first filed | Payment, Tax Withholding, Share-based Payment Arrangement 12 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.20M 10-Q · filed 2026-08-06 | $3.60M derived: sum of 3 quarters · filed 2026-08-06 | $3.90M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.80M 10-Q · filed 2026-05-01 | $3.20M derived: sum of 2 quarters · filed 2026-05-01 | $3.50M derived: sum of 3 quarters · filed 2026-05-01 | $3.70M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $700.00K derived: sum of 2 quarters · filed 2026-02-27 | $900.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.40M 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $500.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.00M 10-Q · filed 2025-10-30 | $1.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $700.00K 10-Q · filed 2026-08-06 | $1.00M derived: sum of 3 quarters · filed 2026-08-06 | $1.30M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $500.00K 10-Q · filed 2026-05-01 | $800.00K derived: sum of 2 quarters · filed 2026-05-01 | $1.10M derived: sum of 3 quarters · filed 2026-05-01 | $1.30M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $600.00K derived: sum of 2 quarters · filed 2026-02-27 | $800.00K derived: sum of 3 quarters · filed 2026-02-27 | $1.20M 10-K · filed 2026-02-27 | ||||
| 2024-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $500.00K derived: sum of 2 quarters · filed 2025-10-30 | $900.00K 10-Q · filed 2025-10-30 | $1.00M derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $600.00K 10-Q · filed 2025-08-07 | $700.00K derived: sum of 3 quarters · filed 2026-02-27 | $800.00K derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2024-03-31 | $400.00K 10-Q · filed 2025-05-08 | $500.00K derived: sum of 2 quarters · filed 2026-02-27 | $600.00K derived: sum of 3 quarters · filed 2026-02-27 | $800.00K derived: sum of 4 quarters · filed 2026-02-27 | ||||
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $200.00K derived: sum of 2 quarters · filed 2026-02-27 | $400.00K derived: sum of 3 quarters · filed 2026-02-27 | $2.50M 10-K · filed 2026-02-27 | ||||
| 2023-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $300.00K derived: sum of 2 quarters · filed 2024-11-07 | $2.40M 10-Q · filed 2024-11-07 | $2.60M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $2.30M 10-Q · filed 2024-08-07 | $2.50M derived: sum of 3 quarters · filed 2025-03-04 | $2.80M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2023-03-31 | $2.10M 10-Q · filed 2024-05-02 | $2.30M derived: sum of 2 quarters · filed 2025-03-04 | $2.60M derived: sum of 3 quarters · filed 2025-03-04 | $3.00M derived: sum of 4 quarters · filed 2025-03-04 | ||||
| 2022-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $500.00K derived: sum of 2 quarters · filed 2025-03-04 | $900.00K derived: sum of 3 quarters · filed 2025-03-04 | $5.90M 10-K · filed 2025-03-04 | ||||
| 2022-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11 | $700.00K derived: sum of 2 quarters · filed 2023-12-11 | $5.70M 10-Q · filed 2023-12-11 | $6.00M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $5.40M 10-Q · filed 2023-08-09 | $5.70M derived: sum of 3 quarters · filed 2024-03-08 | $6.20M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2022-03-31 | $5.00M 10-Q · filed 2023-05-10 | $5.30M derived: sum of 2 quarters · filed 2024-03-08 | $5.80M derived: sum of 3 quarters · filed 2024-03-08 | $6.60M derived: sum of 4 quarters · filed 2024-03-08 | ||||
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $800.00K derived: sum of 2 quarters · filed 2024-03-08 | $1.60M derived: sum of 3 quarters · filed 2024-03-08 | $13.80M 10-K · filed 2024-03-08 | ||||
| 2021-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.30M derived: sum of 2 quarters · filed 2022-11-09 | $13.50M 10-Q · filed 2022-11-09 | $14.50M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-06-30 | $800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $13.00M 10-Q · filed 2022-08-02 | $14.00M derived: sum of 3 quarters · filed 2023-12-11 | $15.10M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2021-03-31 | $12.20M 10-Q · filed 2022-04-29 | $13.20M derived: sum of 2 quarters · filed 2023-12-11 | $14.30M derived: sum of 3 quarters · filed 2023-12-11 | $20.40M derived: sum of 4 quarters · filed 2023-12-11 | ||||
| 2020-12-31 | $1.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | $2.10M derived: sum of 2 quarters · filed 2023-12-11 | $8.20M derived: sum of 3 quarters · filed 2023-12-11 | $13.80M 10-K/A · filed 2023-12-11 | ||||
| 2020-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $7.20M derived: sum of 2 quarters · filed 2021-11-05 | $12.80M 10-Q · filed 2021-11-05 | $13.60M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $6.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $11.70M 10-Q · filed 2021-07-30 | $12.50M derived: sum of 3 quarters · filed 2022-02-25 | $12.80M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $5.60M 10-Q · filed 2021-04-30 | $6.40M derived: sum of 2 quarters · filed 2022-02-25 | $6.70M derived: sum of 3 quarters · filed 2022-02-25 | $7.00M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.10M derived: sum of 2 quarters · filed 2022-02-25 | $1.40M derived: sum of 3 quarters · filed 2022-02-25 | $7.40M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $600.00K derived: sum of 2 quarters · filed 2020-11-06 | $6.60M 10-Q · filed 2020-11-06 | $6.90M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-06-30 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $6.30M 10-Q · filed 2020-07-31 | $6.60M derived: sum of 3 quarters · filed 2021-02-19 | $6.90M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2019-03-31 | $6.00M 10-Q · filed 2020-05-01 | $6.30M derived: sum of 2 quarters · filed 2021-02-19 | $6.60M derived: sum of 3 quarters · filed 2021-02-19 | $6.70M derived: sum of 4 quarters · filed 2021-02-19 | ||||
| 2018-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $600.00K derived: sum of 2 quarters · filed 2021-02-19 | $700.00K derived: sum of 3 quarters · filed 2021-02-19 | $6.60M 10-K · filed 2021-02-19 | ||||
| 2018-09-30 | $300.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $400.00K derived: sum of 2 quarters · filed 2019-11-07 | $6.30M 10-Q · filed 2019-11-07 | $6.30M 10-Q · filed 2018-11-02 | $6.42M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $6.00M 10-Q · filed 2019-08-02 | $6.02M 10-Q · filed 2018-08-03 | $6.12M derived: sum of 3 quarters · filed 2020-02-25 | $6.24M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | $5.90M 10-Q · filed 2019-05-08 | $5.88M 10-Q · filed 2018-05-04 | $6.02M derived: sum of 2 quarters · filed 2020-02-25 | $6.14M derived: sum of 3 quarters · filed 2020-02-25 | $6.18M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $241.00K derived: sum of 2 quarters · filed 2020-02-25 | $285.00K derived: sum of 3 quarters · filed 2020-02-25 | $4.30M 10-K · filed 2020-02-25 | $4.26M 10-K · filed 2018-02-23 | |||
| 2017-09-30 | $125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $169.00K derived: sum of 2 quarters · filed 2018-11-02 | $4.18M 10-Q · filed 2018-11-02 | $694.00K derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $4.06M 10-Q · filed 2018-08-03 | $569.00K derived: sum of 3 quarters · filed 2019-02-22 | $667.00K derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2017-03-31 | $4.01M 10-Q · filed 2018-05-04 | $525.00K derived: sum of 2 quarters · filed 2019-02-22 | $623.00K derived: sum of 3 quarters · filed 2019-02-22 | $738.00K derived: sum of 4 quarters · filed 2019-02-22 | ||||
| 2016-12-31 | -$3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$3.39M derived: sum of 2 quarters · filed 2019-02-22 | -$3.28M derived: sum of 3 quarters · filed 2019-02-22 | $1.10M 10-K · filed 2019-02-22 | $1.14M 10-K · filed 2018-02-23 | |||
| 2016-09-30 | $98.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $213.00K derived: sum of 2 quarters · filed 2017-11-03 | $4.59M 10-Q · filed 2017-11-03 | |||||
| 2016-06-30 | $115.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $4.49M 10-Q · filed 2017-08-04 | ||||||
| 2016-03-31 | $4.38M 10-Q · filed 2017-05-05 | |||||||
| 2015-12-31 | -$1.94M 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |